Form 4 Filing: Russell Steven Jon Sells $53,227.176 of $BBNX
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Russell Steven Jon, holds the title of Chief Medical Officer at Beta Bionics, Inc..
On 2026-06-02, the insider transacted 4,222 shares.The shares were transacted at a weighted average price of $12.61 per share, resulting in a total market-relevant value of $53,227.176.
**Transaction:** sell of 4,222 shares by Russell Steven Jon (Chief Medical Officer). **Strategic Implications (Investor Edge):** While the sale is modest relative to his total holdings, the fact that it is an open market sale by a key C-suite executive (CMO) without a pre-arranged plan could signal a lack of near-term confidence. Investors should monitor for additional insider selling or negative catalysts. **Key Takeaways:** - CMO sold shares on the open market, not via a 10b5-1 plan. - Sale reduced holdings by only 2.4%, which is not a massive liquidation but still notable for a senior executive. - The timing and lack of pre-planning may indicate a bearish view on near-term stock performance.
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.